You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Retroviridae

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-Term Follow-Up of Recipient of Gene Transfer Research

Recruiting
  • Retroviridae Infections
  • Cancer
  • Blood Tests
  • Questionnaires
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 22, 2022

Methods in People Living With Retroviral Infection in Liberia

Active, not recruiting
  • Tuberculosis
  • HIV
    • Bethesda, Maryland
    • +4 more
    Jan 14, 2023

    HIV, AIDS, Immunologic Deficiency Syndrome, Acquired Trial in Boston (Ad26.Mos4.HIV, MVA-BN-HIV, PGT121)

    Recruiting
    • HIV
    • +4 more
    • Ad26.Mos4.HIV
    • +4 more
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Apr 18, 2022

    Human Immunodeficiency Virus, AIDS, HIV Trial in Siaya (Provision of multiple self-tests, Small monetary incentives, Use of

    Enrolling by invitation
    • Human Immunodeficiency Virus
    • +7 more
    • Provision of multiple self-tests
    • +2 more
    • Siaya, Kenya
      Impact Research Development Organization
    May 26, 2022

    HIV Trial in United States (SB-728mR-HSPC Infusion 3 days following busulfan conditioning)

    Active, not recruiting
    • HIV
    • SB-728mR-HSPC Infusion 3 days following busulfan conditioning
    • Duarte, California
    • +4 more
    Mar 7, 2022

    HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

    Suspended
    • HIV Infections
    • BG505 MD39.3 mRNA
    • +2 more
    • Birmingham, Alabama
    • +9 more
    Feb 1, 2023

    HIV Seronegativity, HIV Preventive Vaccine Trial in Johannesburg, Klerksdorp, Cape Town (MVA-C + gp140/MF59, DNA-C2 + MVA-C,

    Completed
    • HIV Seronegativity
    • HIV Preventive Vaccine
    • MVA-C + gp140/MF59
    • +2 more
    • Johannesburg, Gauteng, South Africa
    • +2 more
    Jun 19, 2019

    Acute HIV Infection Trial in China (cART(TDF/AZT+3TC+LPV/r), CTL infusion)

    Unknown status
    • Acute HIV Infection
    • Beijing, Beijing, China
    • +6 more
    Apr 24, 2018

    Retrovirus Epidemiology Donor Study-II (REDS-II)

    Completed
    • Acquired Immunodeficiency Syndrome
    • +12 more
      • (no location specified)
      Apr 14, 2016

      Retrovirus Epidemiology Donor Study I (REDS I)

      Completed
      • Acquired Immunodeficiency Syndrome
      • +8 more
        • (no location specified)
        Apr 14, 2016

        HIV, AIDS, Lentivirus Infections Trial (Circumcision, Flexible sigmoidoscopy)

        Completed
        • HIV Infections
        • +10 more
        • Circumcision
        • Flexible sigmoidoscopy
        • (no location specified)
        Dec 10, 2015

        Infection, Human Immunodeficiency Virus Trial in France, Germany, Spain (GSK2248761 100 mg once daily, GSK2248761 200 mg once

        Terminated
        Has Results
        • Infection, Human Immunodeficiency Virus
        • GSK2248761 100 mg once daily
        • +2 more
        • Levallois Perret, France
        • +11 more
        Oct 16, 2017

        HIV Infection Trial in Aarhus (Panobinostat)

        Completed
        • HIV Infection
        • Aarhus, Denmark
          Department of Infectious Diseases, Aarhus University Hospital
        Feb 24, 2014

        HIV Trial in Canada, United States (MPC-4326 plus a 2-3 drug optimized background regimen (OBR), 3-4 commercially available

        Terminated
        • HIV Infections
        • MPC-4326 plus a 2-3 drug optimized background regimen (OBR)
        • 3-4 commercially available antiretroviral drugs
        • Beverly Hills, California
        • +24 more
        Jun 10, 2010

        Lymphoma, Non-Hodgkin, HIV Trial in Duarte (Peripheral blood stem cells)

        Completed
        • Lymphoma, Non-Hodgkin
        • HIV Infections
        • Peripheral blood stem cells
        • Duarte, California
          City of Hope Natl Med Ctr
        Jun 23, 2005